SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-17-001083
Filing Date
2017-11-13
Accepted
2017-11-13 06:04:23
Documents
1
Period of Report
2017-11-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_5051.html 4  
1 PRIMARY DOCUMENT doc4_5051.xml 4 22868
  Complete submission text file 0001638599-17-001083.txt   25879
Mailing Address BAKER BROS. ADVISORS LP 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address
BAKER JULIAN (Reporting) CIK: 0001087939 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 171192660

Mailing Address BAKER BROS. ADVISORS LP 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address
BAKER FELIX (Reporting) CIK: 0001087940 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 171192662

Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014 2123395600
BAKER BROS. ADVISORS LP (Reporting) CIK: 0001263508 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 171192664

Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014 (212)339-5600
Baker Bros. Advisors (GP) LLC (Reporting) CIK: 0001580575 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 171192663